Therefore, while resveratrol demonstrates HPV‐independent anticancer activity [113], its dual ability to modulate both general tumor biology and CD44‐mediated CSC pathways positions it as a promising option for targeted interventions, especially in HPV‐driven, CD44‐positive cervical cancers. This evidence concerns the gene CD44 and cervical carcinoma.